Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study

NCT: NCT04100135 · TERMINATED

NCT IDNCT04100135
StatusTERMINATED
Start Date2021-02-05
Completion2024-08-15
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief

Frequently Asked Questions

What is GORE® CARDIOFORM Septal Occluder Migraine Clinical Study?

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study is a clinical trial registered under NCT04100135. Current status: TERMINATED.

What is the status of NCT04100135?

The current status of NCT04100135 (GORE® CARDIOFORM Septal Occluder Migraine Clinical Study) is: TERMINATED.

When did GORE® CARDIOFORM Septal Occluder Migraine Clinical Study start?

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study started on 2021-02-05.

Related Devices

PMA P050006Transcatheter septal occluderW. L. Gore & Associates, Inc. K160254GORE DrySeal Flex Introducer SheathW. L. Gore & Associates, Inc. K163217GORE BIO-A Tissue ReinforcementW. L. Gore & Associates, Inc. K163576GORE SYNECOR Preperitoneal BiomaterialW. L. Gore & Associates, Inc. K173333GORE ENFORM BiomaterialW. L. Gore & Associates, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑